Adcytherix
PrivateLast Round
Series A
Oct 16, 2025
Total Funding Raised
$154.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adcytherix is a biopharmaceutical company that develops novel antibody-drug conjugates (ADCs) for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adcytherix Comparables
Compare Adcytherix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sidewinder | 78% | |
| Lonza Group | 77% | |
| TRIO Pharmaceuticals, Inc. | 77% |
Adcytherix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2025 | ||||
| Seed | Jun 11, 2024 |
Key People
Founding team and executive leadership
Adcytherix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series A |
| RA Capital Management | Series A, Seed |
| Andera Partners | Series A |
| Pontifax Venture Capital | Series A, Seed |
| Dawn Biopharma | Series A |
| aMoon | Series A |
| Dawn Biopharma | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 50% QoQ, from 16 to 24 employees.
- Mar 1, 2026
Simon Sturge appointed to reinforce governance during clinical growth phase.
Adcytherix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adcytherix's valuation, stock price, and market status.
Is Adcytherix a public or private company?
Adcytherix is a private company.
What is the current stock price of Adcytherix?
Adcytherix is a private company with no public stock price. No recent secondary market data is available.
How much is Adcytherix worth (valuation)?
Valuation information for Adcytherix is not publicly available.
Can I buy Adcytherix stock?
Adcytherix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Adcytherix's last funding round?
Adcytherix's most recent funding round was Series A on October 16, 2025.
Who are the main investors in Adcytherix?
Key investors in Adcytherix include Andera Partners, Pontifax Venture Capital, Bpifrance, Angelini Ventures, Kurma Partners.
Will Adcytherix IPO soon?
No public IPO plans have been announced for Adcytherix.
How can I track Adcytherix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adcytherix's secondary market activity and sign up for updates.